Nelson Brito

options sniper
trading coach

[Nelson Brito @NeilFoxster]

$LITE pullback to $950–$1,000
$AVGO pullback to $310–$330
$MRVL pullback to $240–$260
$PLTR pullback to $160–$180
$INTC pullback to $105–$115
$TSM pullback to $420–$440

If share prices pull back to these ranges, the risk-to-reward ratio will improve significantly, unlocking massive upside potential.

I will continue to provide updates on more precise entry points.

Don't want to miss the buying ranges for these stocks? Click the "Follow" button and join us.

(Not financial advice — DYOR)

[Nelson Brito @NeilFoxster]

If I had $100,000 to invest today, here's exactly how I'd split it today ‼️
No over-diversifying.
🔥 Keep a close eye on these 6 stocks! The real opportunity to get in is only when they pull back to the following price ranges:
1) $AVGO

[Nelson Brito @NeilFoxster]

$LITE pullback to $950–$1,000
$AVGO pullback to $310–$330
$MRVL pullback to $240–$260
$PLTR pullback to $160–$180
$INTC pullback to $105–$115
$TSM pullback to $420–$440

If share prices pull back to these ranges, the risk-to-reward ratio will improve significantly, unlocking massive upside potential.

I will continue to provide updates on more precise entry points.

Don't want to miss the buying ranges for these stocks? Click the "Follow" button and join us.

(Not financial advice — DYOR)

[Nelson Brito @NeilFoxster]

If I had $100,000 to invest today, here's exactly how I'd split it today ‼️
No over-diversifying.
🔥 Keep a close eye on these 6 stocks! The real opportunity to get in is only when they pull back to the following price ranges:
1) $AVGO

[Nelson Brito @NeilFoxster]

Here are the biotech stocks that can 10x:

1. $RXRX (Recursion): AI phenomics + multi-omics platform with Roche/Genentech, Sanofi, NVIDIA and Tempus partnerships driving external validation and milestone inflows. Reusable discovery engine plus internal pipeline positions it for multi-program upside.

2. $MRNA (Moderna): Seasonal respiratory vaccine franchise (COVID + newly approved mRNA flu) funds oncology and rare-disease mRNA shots. Fat cash pile (~$7B) and reusable platform support the path to cash breakeven while delivering ~10% guided growth.

3. $TEM (Tempus AI): Oncology diagnostics + pharma data/AI dual engine with TTM revenue ~$1.43B (+50%) and 2026 guide ~$1.60B (+25%). Remaining contract value >$1.1B and high-margin data flywheel create durable compounding potential.

4. $CRSP (CRISPR Therapeutics): First approved CRISPR therapy CASGEVY scaling rapidly (Vertex Q2 sales $76M, +78% QoQ / +151% YoY) with pediatric expansion and in vivo pipeline. $2.36B+ cash funds the next wave of gene-editing programs.

5. $HIMS (Hims & Hers): Consumer health platform with nearly 3M subscribers, TTM revenue ~$2.58B (+28%), and raised 2026 guide $3.1–$3.3B. GLP-1 weight loss + testosterone + women's health + international scale-up drive high-growth recurring revenue.

6. $IBRX (ImmunityBio): ANKTIVA on an 8-quarter sequential streak with 2025 product revenue $113M (+700%) and H1 2026 $94.8M (+121%). Expanding into NSCLC and global labels turns early commercial traction into multi-indication upside.

7. $IOVA (Iovance): Amtagvi (first approved TIL therapy) driving raised 2026 revenue guide $410–$420M (~60% growth) on strong U.S. demand and expanding ATC network. NSCLC opportunity ~7x larger than melanoma + next-gen TILs create multi-bagger commercial and pipeline leverage.

8. $NVAX (Novavax): Matrix-M adjuvant platform powering Sanofi, Takeda and other partnerships with milestone/royalty upside and $700M+ cash. Shift to lean, partner-driven model plus combination vaccine potential offers high-upside optionality from a beaten-down base.

The next 10x play will be posted in my free group building generational wealth.

Daily setups. Live calls. Find 10x plays before they run.

📌 If this helped → Like + Follow + Share
❗(Not financial advice — DYOR)

[Nelson Brito @NeilFoxster]

1 year ago $BE: $20 → +1,655% → $351 🚀

Now — same setup. Same logic.

8 biotech stocks still trading at "early $BE" prices:

1. $NVAX

[Nelson Brito @NeilFoxster]

$VIVK — Break & hold above $5.25–$5.32
🎯 Targets: $5.50–$6.50+

[Nelson Brito @NeilFoxster]

🚨 TODAY'S WATCHLIST — OCT 09, 2026 🚨

$VEEA — Break & hold above $6.15
🎯 Targets: $6.50–$8.50+

$NTCL — Break & hold above $2.42
🎯 Targets: $2.65–$4.00+

$SAIQ — Break & hold above $7.06
🎯 Targets: $7.39–$9.94+

$XRTX — Break & hold above $2.32
🎯 Targets: $2.46–$3.50+

$CLOV — Break & hold above $5.18
🎯 Targets: $5.35–$6.25+

[Nelson Brito @NeilFoxster]

$VIVK — Break & hold above $5.25–$5.32
🎯 Targets: $5.50–$6.50+

[Nelson Brito @NeilFoxster]

🚨 TODAY'S WATCHLIST — OCT 09, 2026 🚨

$VEEA — Break & hold above $6.15
🎯 Targets: $6.50–$8.50+

$NTCL — Break & hold above $2.42
🎯 Targets: $2.65–$4.00+

$SAIQ — Break & hold above $7.06
🎯 Targets: $7.39–$9.94+

$XRTX — Break & hold above $2.32
🎯 Targets: $2.46–$3.50+

$CLOV — Break & hold above $5.18
🎯 Targets: $5.35–$6.25+

[Nelson Brito @NeilFoxster]

@Jeremy_Lefcn7l stock

[Nelson Brito @NeilFoxster]

Rep. Michael Rulli bought $1K to $15K on Sept 3

2/6 Snowflake $SNOW
Rep. Maria Elvira Salazar bought $15K to $50K on Sept 4

3/6 IBM $IBM
Rep. Lloyd Doggett bought $1K to $15K on Sept 10

4/6 Microsoft $MSFT
Rep. Cleo Fields bought $1K to $15K on Sept 10

5/6 PepsiCo $PEP
Rep. Scott Franklin bought $1K to $15K on Aug 26

6/6 Meta $META
Rep. Maria Elvira Salazar bought $1K to $15K on Sept 22

Then remember to follow me and subscribe
❗(Not financial advice — DYOR)

[Nelson Brito @NeilFoxster]

MEMBERS OF CONGRESS ARE BUYING THESE STOCKS ‼️

Disclosed trades from the last 45 days show where House representatives put their own money

Here are 6 names on their purchase slips 👇

1/6 Goldman Sachs $GS

[Nelson Brito @NeilFoxster]

Rep. Michael Rulli bought $1K to $15K on Sept 3

2/6 Snowflake $SNOW
Rep. Maria Elvira Salazar bought $15K to $50K on Sept 4

3/6 IBM $IBM
Rep. Lloyd Doggett bought $1K to $15K on Sept 10

4/6 Microsoft $MSFT
Rep. Cleo Fields bought $1K to $15K on Sept 10

5/6 PepsiCo $PEP
Rep. Scott Franklin bought $1K to $15K on Aug 26

6/6 Meta $META
Rep. Maria Elvira Salazar bought $1K to $15K on Sept 22

Then remember to follow me and subscribe
❗(Not financial advice — DYOR)

[Nelson Brito @NeilFoxster]

MEMBERS OF CONGRESS ARE BUYING THESE STOCKS ‼️

Disclosed trades from the last 45 days show where House representatives put their own money

Here are 6 names on their purchase slips 👇

1/6 Goldman Sachs $GS

[Nelson Brito @NeilFoxster]

Here are 5 stocks that can 10x in the next few years:
$ASTS

$RKLB

$SATL

$INFQ

$NVDA

Same playbook. Same edge. Bookmark this. You’ll thank yourself when the next leg higher starts

📌 If this cross-sector premarket approach is useful, a like, follow, and share is enough.

📷 For the daily notes, the Discord channel is in my bio.

[Nelson Brito @NeilFoxster]

I'm only going to say this TWICE.

If you're under 49, the incoming market CRASH will be a generational time to BUY insanely undervalued stocks at a discount.

Here are 5 stocks I believe can 10x:

1. $NVDA

[Nelson Brito @NeilFoxster]

@Jeremy_Lefcn7l stock

[Nelson Brito @NeilFoxster]

@Jeremy_Lefcn7l stock

[Nelson Brito @NeilFoxster]

Here are 5 stocks that can 10x in the next few years:
$ASTS

$RKLB

$SATL

$INFQ

$NVDA

Same playbook. Same edge. Bookmark this. You’ll thank yourself when the next leg higher starts

📌 If this cross-sector premarket approach is useful, a like, follow, and share is enough.

📷 For the daily notes, the Discord channel is in my bio.

[Nelson Brito @NeilFoxster]

I'm only going to say this TWICE.

If you're under 49, the incoming market CRASH will be a generational time to BUY insanely undervalued stocks at a discount.

Here are 5 stocks I believe can 10x:

1. $NVDA